Impact of Pre-transplant Therapy and Depth of Disease Response prior to Autologous Transplantation for Multiple Myeloma

Patients with multiple myeloma (MM), who are eligible for autologous stem cell transplantation (ASCT), typically receive a finite period of initial therapy prior to ASCT. It is not clear if patients with suboptimal (less than a partial) response to initial therapy benefit from additional alternative...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:Biol Blood Marrow Transplant
Hauptverfasser: Vij, Ravi, Kumar, Shaji, Zhang, Mei-Jie, Zhong, Xiaobo, Huang, Jiaxing, Dispenzieri, Angela, Abidi, Muneer H., Bird, Jennifer M., Freytes, César O., Gale, Robert Peter, Kindwall-Keller, Tamila L., Kyle, Robert A., Landsburg, Daniel J., Lazarus, Hillard M., Munker, Reinhold, Roy, Vivek, Sharma, Manish, Vogl, Dan T., Wirk, Baldeep, Hari, Parameswaran N.
Format: Artigo
Sprache:Inglês
Veröffentlicht: 2014
Schlagworte:
Article
Online Zugang:https://ncbi.nlm.nih.gov/pmc/articles/PMC4297511/
https://ncbi.nlm.nih.gov/pubmed/25445028
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.bbmt.2014.10.023
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!

Ähnliche Einträge